Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes

Clinical Cancer Research

Volumn 2, Issue 10, 1996, Pages 1731-1741

  Sandoval, Alex ^a   Consoli, Ugo ^a   Plunkett, William ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA REPAIR; HUMAN; HUMAN CELL; LYMPHOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; DNA FRAGMENTATION; DNA REPAIR; FLOW CYTOMETRY; HUMANS; LYMPHOCYTES; ULTRAVIOLET RAYS; VIDARABINE;

EID: 0029859821     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Plunkett, W , and Saunders, P. Metabolism and action of purine nucleoside analogs. In: G. Powis (ed.), Anticancer Drugs: Antimetabolite Metabolism and Natural Anticancer Agents, pp. 95-137 Oxford, U.K.: Pergamon Press Ltd., 1994.
2. Daher, G. C., Harris, B. E., and Diasio, R. B. Metabolism of pyrimidine analogues and their nucleosides. Pharmacol. & Ther., 48: 189-222, 1990.
3. Gandhi, V., Kenema, A., Keating, M. J., and Plunkett, W. Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy. Leuk. & Lymphoma, 10: 49-56, 1993.
4. Keating, M. J., Kantarjian, H., Talpaz, M., Redman, J., Koller, C , Barlogie, B., Velasquez, W., Plunkett, W., Freireich, E. J., and McCredie, K. B. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood, 74: 19-25, 1989.
5. O'Bricn, S., Kantarjian, H , Beran, M., Smith, T., Koller, C., Estey, E , Robertson, L. E , Lerner, S., and Keating, M. Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment. Blood, 82: 1695-1700, 1993.
6. McLaughlin, P., Hagemeister, F. B., Swan, F., Cabanillas, F., Pate, O., Romaguera, J. E., Rodriguez, M. A., Redman, J. R., and Keating, M. Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma. J. Clin. Oncol., 12: 575-579, 1994.
7. Redman, J. R., Cabanillas, F., Velasquez, W. S., McLaughlin, P., Hagemeister, F. B., Swan, F., Rodriguez, M. A., Plunkett, W., and Keating, M. J. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma. J. Clin. Oncol., 10: 790-794, 1992.
8. Gandhi, V., Estey, E., Keating, M. J., and Plunkett, W. Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. J. Clin. Oncol., 11: 116-124, 1993.
9. Gandhi, V. Fludarabine for treatment of adult acute myelogenous leukemia. Leuk. & Lymphoma, 11;(Suppl. 2): 7-13, 1993.
10. Estey, E., Thall, P., Andreeff, M., Beran, M., Kantarjian, H., O'Brien, S., Escudier, S., Robertson, L. E., Koller, C., Kornblau, S., Pierce, S., Freireich, E. J., Deisseroth, A., and Keating, M. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. J. Clin. Oncol., 12: 671-678, 1994.
11. Foss, F. M., Ihde, D. C., Linnoila, I. R., Fischmann, A. B., Schechter, G. P., Cotelingam, J. D., Steinberg, S. M., Ghosh, B. C., Stocker, J. L., Bastian, A., Phares, J. C., and Sausville, E. A. Phase II trial of fludarabine phosphate and interferon α-2a in advanced mycosis fungoides/Sézary syndrome. J. Clin Oncol., 12: 2051-2059, 1994.
12. Tseng, W-C., Derse, D., Cheng, Y-C., Brockman, R. W , and Bennett, L. L. In vitro biological activity of 9-β-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. Mol Pharmacol., 21: 474-477, 1982.
13. Huang, P., and Plunkett, W. Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event. Cancer Chemother. Pharmacol, 36: 181-188, 1995.
14. Huang, P , Chubb, S., and Plunkett, W. Termination of DNA synthesis by 9-β-D-arabinofuranosyl-2-fluoroadenine, a mechanism for cytotoxicity. J. Biol. Chem., 265: 16617-16625, 1990.
15. Catapano, C. V., Perrino, F. W., and Femandes, D. J. Primer RNA chain termination induced by 9-β-D-arabinofuranosyl-2-fluoroadenine 5′-triphosphate. J. Biol. Chem., 268: 7179-7185, 1993.
16. Kamiya, K., Huang, P., and Plunkett, W. Inhibition of the 3′ → 5′ exonuclease of human DNA polymerase ∈ by fludarabine-terminated DNA. J. Biol. Chem., 271: 19428-19435, 1996.
17. Yang, S-W., Huang, P., Plunkett, W., Becker, F., and Chan, J. Y. H. Dual mode of inhibition of purified DNA ligase I from human cells by 9-β-D-arabinofuranosyl-2-fluoroadenine. J. Biol Chem., 267: 2345-2349, 1992.
18. Huang, P., Siciliano, M. J., and Plunkett, W. Gene deletion, a mechanism of induced mutation by arabinosyl nucleosides. Mutat. Res., 210: 291-301, 1989.
19. Snyder, R. D. Effect of 2′-deoxy-2'′-(fluoromethylene) cytidine on the ultraviolet and X-ray sensitivity of HeLa cells. Oncol. Res., 6: 177-182, 1994.
20. Mirzayans, R., Dietrich, K., and Paterson, M. C. Aphidicolin and 1-β-D-arabinofuranosylcytosine strongly inhibit transcriptionally active DNA repair in normal human fibroblasts. Carcinogenesis (Lond.), 14: 2621-2626, 1993.
21. Cleaver, J. E. Structure of repaired sites in human DNA synthesized in the presence of inhibitors of DNA polymerases α and β in human fibroblasts. Biochim. Biophys. Acta, 739: 301-311, 1983.
22. Dunn, W. C., and Regan, J. D. Inhibition of DNA excision repair in human cells by arabinofuranosylcytosine: effect on normal and xeroderma pigmentosum cells. Mol. Pharmacol., 15: 367-374, 1979.
23. Robertson, L E., Kantarjian, H., O'Brien, S., Yang, L. Y., Gandhi, V , Lcrner, S., Plunkett, W., and Keating, M. J. Cisplatin, fludarabine, and ara-C (PFA): a regimen for advanced fludarabine refractory chronic lymphocytic leukemia (CLL). Proc. Am. Soc. Clin. Oncol., 12: 308, 1993.
24. Aboussekhra, A., and Wood, R. D. Repair of UV-damaged DNA by mammalian cells and Saccharomyces cerevisiae. Curr. Opin. Genet. Dev., 4: 212-220, 1994.
25. Friedberg, E. C. DNA repair: looking back and peering forward. BioEssays, 16. 645-649, 1994.
26. Sancar, A., and Tang, M-S. Nucleotide excision repair. Photochem. Photobiol., 57: 905-921, 1993.
27. Budd, M. E., and Campbell, J. L. DNA polymerases required for repair of UV-induced damage in Saccharomyces cerevisiae. Mol. Cell. Biol., 115: 2173-2179, 1995.
28. Chalut, C., Moncollin, V., and Egly, J. M. Transcription by RNA polymerase II: a process linked to DNA repair. BioEssays, 16: 651-655, 1994.
29. Friedberg, E. C., Bardwell, A. J., Bardwell, L., Wang, Z., and Dianov, G. Transcription and nucleotide excision repair, reflections, considerations, and recent biochemical insights. Mutat. Res., 307: 5-14, 1994.
30. Drapkin, R., Sancar, A., and Reinberg, D. Where transcription meets repair. Cell, 77: 9-12, 1994.
31. Selby, C. P., and Sancar, A. Molecular mechanism of transcription-repair coupling. Science (Washington DC), 260: 53-58, 1993.
32. Evans, R. G., and Norman, A. Unscheduled incorporation of thymidine in ultraviolet-irradiated human lymphocytes. Radiat. Res., 36: 287-298, 1968.
33. Plunkett, W., Chubb, S., Alexander, L., and Montgomery, J. A. Comparison of the toxicity and metabolism of 9-β-D-arabinofuranosyl-2-fluoroadenine and 9-β-D-arabinofuranosyladenine in human lymphoblastoid cells. Cancer Res., 40. 2349-2355, 1980.
34. Gandhi, V., and Plunkett, W. Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells. Cancer Res., 48: 329-334, 1988.
35. Huang, P , and Plunkett, W. A quantitative assay for fragmented DNA in apoptotic cells. Anal. Biochem., 207: 163-167, 1992.
36. Gorczyca, W., Gong, J., and Darzynkiewicz, Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53: 1945-1951, 1993.
37. Evans, R. G., and Norman, A. Radiation-stimulated incorporation of thymidine into the DNA of human lymphocytes. Nature (Lond.), 217: 455-456, 1968.
38. Conner, W. G., and Norman, A. Unscheduled DNA synthesis in human lymphocytes. Mutat. Res., 13: 393-402, 1971.
39. Freeman, S E., and Ryan, S L Excision repair of pyrimidine dimers in human peripheral blood lymphocytes: comparison between stimulated and unstimulated cells. Mutat. Res., 194: 143-150, 1988.
40. Darzynkiewicz, Z. Radiation-induced DNA synthesis in normal and stimulated human lymphocytes Exp. Cell Res., 69: 356-360, 1971.
41. Spriggs, D., Robbins, G., Mitchell, T., and Kufe, D. Incorporation of 9-β-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA. Biochem. Pharmacol., 35: 247-252, 1986.
42. Huang, P., and Plunkett, W. Action of 9-β-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism. Mol. Pharmacol., 39: 449-455, 1991.
43. Cohen, G. M., Sun, X-M., Fearnhead, H., MacFarlane, M., Brown, D. G., Snowden, R. T., and Dinsdale, D. Formation of large molecular weight fragments of DNA is a key step of apoptosis in thymocytes. J. Immunol., 153: 507-516, 1994.
44. Walker, P. R., Weaver, V. M., Lach, B., LeBlanc, J , and Sikorska, M. Endonuclease activities associated with high molecular weight and internucleosomal DNA fragmentation in apoptosis. Exp. Cell Res., 213: 100-106, 1994.
45. Brown, D. G., Sun, X-M., and Cohen, G. M. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem., 268: 3037-3039, 1993.
46. Huang, P., Robertson, L. E., Wright, S., and Plunkett, W. High molecular weight DNA fragmentation: a critical event in nucleoside analog-induced apoptosis in leukemia cells. Clin. Cancer Res., 1: 1005-1013, 1995.
47. Evans, D. L., and Dive, C. Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res., 53: 2133-2139, 1993.
48. Del Bino, G., Bruno, S., Yi, P. N., and Darzynkiewicz, Z. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation. Cell Proliferation, 25: 537-548, 1992
49. Colombel, M., Olsson, C. A., Ng, P-Y , and Buttyan, R. Hormoneregulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res., 52: 4313-4319, 1992.
50. Fotedar, R., Flatt, J., Gupta, S., Margolis, R. L., Fitzgerald, P., Messier. H., and Fotedar, A. Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. Mol Cell. Biol., 15: 932-942, 1995.
51. Radvanyi, L. G., Mills, G. B., and Miller, R. G. Rehgation of the T-cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J. Immunol., 150: 5704-5715, 1993.
52. Boehme, S. A., and Lenardo, M. J. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol., 23: 1552-1560, 1993.
53. Szymkowski, D. E., Lawrence, C. W., and Wood, R. D. Repair by human cell extracts of single (6-4) and cyclobutane thymine-thymine photoproducts in DNA. Proc. Natl. Acad. Sci. USA, 90: 9823-9827, 1993.
54. Broughton, B. C., Lehmann, A. R., Harcourt, S. A., Arlett, C. F., Sarasin, A., Kleijer, W. J., Beemer, F. A., Nairn, R., and Mitchell, D. L. Relationship between pyrimidine dimers, 6-4 photoproducts, repair synthesis, and cell survival: studies using cells from patients with trichothiodystrophy. Mutat. Res., 235: 33-40, 1990.
55. Bradley, M. O., and Taylor, V. I. Repair-induced DNA double strand breaks after ultraviolet-light and either aphidocolin or 1-β-D-arabinofuranosyl-cytosine/hydroxyurea. Carcinogenesis (Lond.), 4: 1513-1517, 1983.
56. Mitchell, D. L., Nguyen, T. D., and Cleaver, J. E. Nonrandom induction of pyrimidine-pyrimidone (6-4) photoproducts in ultravioletirradiated human chromatin. J. Biol. Chem., 265: 5353-5356, 1990
57. Jayanth, R. V., and Hittelman, W. N. 9-β-D-arabinofuranosyl-2-fluoroadenine (F-ara-A) inhibits both the fast and slow components of chromosome repair. In: J. D. Chapman, W. C. Dewey, and G. F. Whitmore (eds.), Radiation Research: A Twentieth Century Perspective, Vol. 1, p. 411. San Diego, CA: Academic Press, 1991.
58. Yang, L-Y., Li, L., Keating, M. J., and Plunkett, W. Fludarabine triphosphate inhibition of DNA excision repair of cisplatin-induced DNA adducts in a cell-free system. Mol. Pharmacol., 47: 1072-1079, 1995.
59. Gregoire, V , Hunter, N., Milas, L., Brock, W. A., Plunkett, W., and Hittelman, W. N. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine. Cancer Res., 54: 468-474, 1994.
60. Gregoire, V , Nguyen, T., Van, L., Stephens, C., Brock, W. A., Milas, L., Plunkett, W., and Hittelman, W. N. The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. Cancer Res., 54: 6201-6209, 1994.
61. Danhauser, L., Plunkett, W., Keating, M. J., and Cabanillas, F. 9-β-D-arabinofuranosyl-2-fluoroadenine 5′-monophosphate pharmacokinetics in plasma and tumor cells of patients with relapsed leukemia and lymphoma. Cancer Chemother. Pharmacol., 18: 145-152, 1986.
62. Yang, L. Y., Liu, X. M., Keating, M. J., and Plunkett, W. Gemcitabine suppresses the repair of cisplatin adducts in plasmid DNA by extracts of cisplatin-resistant human colon carcinoma cells. Proc. Am. Assoc. Cancer Res., 36: 357, 1995.
63. Crino, L., Scagliotti, G., Marangolo, M., Figoli, F., Clerici, M., De Marinis, F., Salvati, F., Cruciani, G., Dogliotti, L., Cocconi, G., Paccagnella, A., Adamo, V., Incoronato, P., Scarcells, L., Mosconi, A M., and Tonato, M. Cisplatin-gemcitabine combination in non-small cell lung cancer (NSCLC): a phase II study. Proc. Am. Soc. Oncol., 14: 352. 1995.